UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016852 |
|---|---|
| Receipt number | R000019542 |
| Scientific Title | Phase II study of Gemcitabine + nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer |
| Date of disclosure of the study information | 2015/03/23 |
| Last modified on | 2020/07/01 18:16:39 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/03/20 14:54:58 | ||
| 2 | Update | 2015/03/24 05:31:33 | Key inclusion criteria |
|
| 3 | Update | 2018/03/22 14:08:48 | Name of primary person or sponsor Department Organization |
|
| 4 | Update | 2019/03/25 22:54:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Email1 Organization Organization Address Address Tel |
|
| 5 | Update | 2019/03/25 22:57:09 | Date of IRB Last follow-up date |
|
| 6 | Update | 2020/04/11 13:50:07 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2020/07/01 18:16:39 | Recruitment status |
